Semaglutide is gaining traction as a novel treatment for insulin resistance. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist functions through stimulating the pancreas to secrete more insulin and https://estelleadwl483850.therainblog.com/34537638/understanding-semaglutide-a-comprehensive-guide